Insights

Loading spinner
Gathering insights about Vicore Pharma AB

Vicore Pharma AB Tech Stack

Vicore Pharma AB uses 8 technology products and services including oEmbed, Google Fonts API, IQVIA, and more. Explore Vicore Pharma AB's tech stack below.

  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • IQVIA
    Health Platform
  • JSON-LD
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • HTTP/3
    Web & Portal Technology
  • Nginx
    Web Servers

Media & News

Vicore Pharma AB's Email Address Formats

Vicore Pharma AB uses at least 1 format(s):
Vicore Pharma AB Email FormatsExamplePercentage
First.Last@vicorepharma.comJohn.Doe@vicorepharma.com
88%
Last.F@vicorepharma.comDoe.J@vicorepharma.com
5%
First.Middle.Last@vicorepharma.comJohn.Michael.Doe@vicorepharma.com
5%
First.Middle@vicorepharma.comJohn.Michael@vicorepharma.com
2%

Frequently Asked Questions

What is Vicore Pharma AB's phone number?

Minus sign iconPlus sign icon
You can contact Vicore Pharma AB's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vicore Pharma AB's official website and social media links?

Minus sign iconPlus sign icon
Vicore Pharma AB's official website is vicorepharma.com and has social profiles on LinkedInCrunchbase.

What is Vicore Pharma AB's SIC code NAICS code?

Minus sign iconPlus sign icon
Vicore Pharma AB's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Vicore Pharma AB have currently?

Minus sign iconPlus sign icon
As of December 2025, Vicore Pharma AB has approximately 51 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: A. M.Cfo: H. J.Chief Medical Officer: B. E. L.. Explore Vicore Pharma AB's employee directory with LeadIQ.

What industry does Vicore Pharma AB belong to?

Minus sign iconPlus sign icon
Vicore Pharma AB operates in the Pharmaceutical Manufacturing industry.

What technology does Vicore Pharma AB use?

Minus sign iconPlus sign icon
Vicore Pharma AB's tech stack includes oEmbedGoogle Fonts APIIQVIAJSON-LDModernizrGoogle MapsHTTP/3Nginx.

What is Vicore Pharma AB's email format?

Minus sign iconPlus sign icon
Vicore Pharma AB's email format typically follows the pattern of First.Last@vicorepharma.com. Find more Vicore Pharma AB email formats with LeadIQ.

How much funding has Vicore Pharma AB raised to date?

Minus sign iconPlus sign icon
As of December 2025, Vicore Pharma AB has raised $10M in funding. The last funding round occurred on Sep 30, 2024 for $10M.

When was Vicore Pharma AB founded?

Minus sign iconPlus sign icon
Vicore Pharma AB was founded in 2009.

Vicore Pharma AB

Pharmaceutical ManufacturingStockholm, Sweden51-200 Employees

Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. Almee™ (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. Using its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company’s shares (VICO) are listed on Nasdaq Stockholm’s main market. For more information, see www.vicorepharma.com.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $10M

    Vicore Pharma AB has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $10M.

  • $1M$10M

    Vicore Pharma AB's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $10M

    Vicore Pharma AB has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $10M.

  • $1M$10M

    Vicore Pharma AB's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.